Berenberg Bank restated their buy rating on shares of NMC Health (LON:NMC) in a report released on Monday, January 29th. They currently have a GBX 4,000 ($55.26) price objective on the stock.
Several other research analysts have also weighed in on the company. JPMorgan Chase & Co. lowered NMC Health to a neutral rating and lifted their target price for the stock from GBX 2,730 ($37.72) to GBX 3,270 ($45.18) in a report on Wednesday, January 24th. Jefferies Group reiterated a hold rating and set a GBX 3,085 ($42.62) target price on shares of NMC Health in a report on Wednesday, January 17th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has an average rating of Buy and an average price target of GBX 3,377 ($46.66).
Shares of NMC Health (NMC) traded down GBX 12 ($0.17) during trading on Monday, hitting GBX 3,256 ($44.98). The company had a trading volume of 253,603 shares, compared to its average volume of 346,142. The firm has a market capitalization of $6,630.00 and a PE ratio of 5,613.79. NMC Health has a twelve month low of GBX 1,710 ($23.63) and a twelve month high of GBX 3,540 ($48.91).
In related news, insider Patrick James Meade (Lord Clanwilliam) bought 3,000 shares of the stock in a transaction that occurred on Monday, February 5th. The shares were acquired at an average price of GBX 3,198 ($44.18) per share, with a total value of £95,940 ($132,550.43). Also, insider Jonathan Bomford bought 1,000 shares of the stock in a transaction that occurred on Monday, November 27th. The stock was bought at an average cost of GBX 2,877 ($39.75) per share, for a total transaction of £28,770 ($39,748.55). Over the last 90 days, insiders bought 32,160 shares of company stock worth $94,402,800.
ILLEGAL ACTIVITY NOTICE: “NMC Health (NMC) Earns “Buy” Rating from Berenberg Bank” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/nmc-health-nmc-stock-rating-reaffirmed-by-berenberg-bank.html.
NMC Health Company Profile
NMC Health plc is a private healthcare services provider in the United Arab Emirates. The Company operates through two segments: healthcare and distribution & services. The healthcare segment is engaged in providing professional medical services, comprising diagnostic services, in and outpatient clinics, provision of all types of research and medical services in the field of gynecology, obstetrics and human reproduction and retailing of pharmaceutical goods.
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.